182 related articles for article (PubMed ID: 10180650)
1. The iterative use of economic evaluation as part of the process of health technology assessment.
Sculpher M; Drummond M; Buxton M
J Health Serv Res Policy; 1997 Jan; 2(1):26-30. PubMed ID: 10180650
[TBL] [Abstract][Full Text] [Related]
2. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies.
Claxton K
J Health Econ; 1999 Jun; 18(3):341-64. PubMed ID: 10537899
[TBL] [Abstract][Full Text] [Related]
3. Handling uncertainty in economic evaluations of healthcare interventions.
Briggs AH; Gray AM
BMJ; 1999 Sep; 319(7210):635-8. PubMed ID: 10473486
[No Abstract] [Full Text] [Related]
4. Cost collection and analysis for health economic evaluation.
Smith KA; Rudmik L
Otolaryngol Head Neck Surg; 2013 Aug; 149(2):192-9. PubMed ID: 23641023
[TBL] [Abstract][Full Text] [Related]
5. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
Williams I; Bryan S; McIver S
J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
[TBL] [Abstract][Full Text] [Related]
6. Use of evidence in economic decision models: practical issues and methodological challenges.
Cooper NJ; Sutton AJ; Ades AE; Paisley S; Jones DR;
Health Econ; 2007 Dec; 16(12):1277-86. PubMed ID: 18034447
[TBL] [Abstract][Full Text] [Related]
7. Economic appraisal in the British National Health Service: implications of recent developments.
Henshall C; Drummond M
Soc Sci Med; 1994 Jun; 38(12):1615-23. PubMed ID: 8047919
[TBL] [Abstract][Full Text] [Related]
8. Aggregate Distributional Cost-Effectiveness Analysis of Health Technologies.
Love-Koh J; Cookson R; Gutacker N; Patton T; Griffin S
Value Health; 2019 May; 22(5):518-526. PubMed ID: 31104729
[TBL] [Abstract][Full Text] [Related]
9. Problems of using modelling in the economic evaluation of health care.
Sheldon TA
Health Econ; 1996; 5(1):1-11. PubMed ID: 8653188
[No Abstract] [Full Text] [Related]
10. COMPARISON OF METHODS FOR ESTIMATING CONTEMPORARY COSTS: AN APPLICATION TO LIVER TRANSPLANTATION IN THE UNITED KINGDOM.
Singh J; Longworth L
Int J Technol Assess Health Care; 2017 Jan; 33(6):620-628. PubMed ID: 28934994
[TBL] [Abstract][Full Text] [Related]
11. Unrelated Future Costs and Unrelated Future Benefits: Reflections on NICE Guide to the Methods of Technology Appraisal.
Morton A; Adler AI; Bell D; Briggs A; Brouwer W; Claxton K; Craig N; Fischer A; McGregor P; van Baal P
Health Econ; 2016 Aug; 25(8):933-8. PubMed ID: 27374115
[TBL] [Abstract][Full Text] [Related]
12. Representing uncertainty: the role of cost-effectiveness acceptability curves.
Fenwick E; Claxton K; Sculpher M
Health Econ; 2001 Dec; 10(8):779-87. PubMed ID: 11747057
[TBL] [Abstract][Full Text] [Related]
13. Medical technology assessment: economic evaluation of new technologies.
Adang EM; Dirksen CD; Engel GL; Baeten CG
Br J Hosp Med; 1995 Jun 7-20; 53(11):563-6. PubMed ID: 7655753
[TBL] [Abstract][Full Text] [Related]
14. The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation.
Picot J; Copley V; Colquitt JL; Kalita N; Hartwell D; Bryant J
Health Technol Assess; 2015 Aug; 19(69):1-190. PubMed ID: 26323045
[TBL] [Abstract][Full Text] [Related]
15. Economic evaluation: an introduction.
Raftery J
BMJ; 1998 Mar; 316(7136):1013-4. PubMed ID: 9550969
[No Abstract] [Full Text] [Related]
16. Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods.
O'Brien BJ; Briggs AH
Stat Methods Med Res; 2002 Dec; 11(6):455-68. PubMed ID: 12516984
[TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness scenario analysis for a proposed trial of hormone replacement therapy.
Townsend J; Buxton M
Health Policy; 1997 Mar; 39(3):181-94. PubMed ID: 10165460
[TBL] [Abstract][Full Text] [Related]
18. Searching for a threshold - Not so NICE..
Mooney G; Coast J; Jan S; ; Ryan M; Wiseman V
J Health Serv Res Policy; 2007 Jul; 12(3):190; author reply 190-1. PubMed ID: 17716427
[No Abstract] [Full Text] [Related]
19. A Bayesian approach to economic analyses of clinical trials: the case of stenting versus balloon angioplasty.
Al MJ; Van Hout BA
Health Econ; 2000 Oct; 9(7):599-609. PubMed ID: 11103926
[TBL] [Abstract][Full Text] [Related]
20. Integrating health economics modeling in the product development cycle of medical devices: a Bayesian approach.
Vallejo-Torres L; Steuten LM; Buxton MJ; Girling AJ; Lilford RJ; Young T
Int J Technol Assess Health Care; 2008; 24(4):459-64. PubMed ID: 18828941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
